| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/24/2013 | CN101979093B Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 04/24/2013 | CN101974046B New natural antipodal kaurane derivative and preparation method and application thereof |
| 04/24/2013 | CN101966182B Compound brain protection preparation and preparation method thereof |
| 04/24/2013 | CN101935331B Novel 4,5-pyrazoline ring-containing helicid medicament with sedative activity and preparation method thereof |
| 04/24/2013 | CN101815512B Cyclopropyl aryl amide derivatives and uses thereof |
| 04/24/2013 | CN101809021B Octahydro-pyrrolo[3,4-b]pyrrole N-oxides |
| 04/24/2013 | CN101785762B Huperzine A orally disintegrating tablets and preparation method thereof |
| 04/24/2013 | CN101686976B Stable solid preparation comprising 4,5-epoxymorphinan derivative |
| 04/24/2013 | CN101664541B Medicament for treating dysmenorrhoea and preparation method thereof |
| 04/24/2013 | CN101627014B Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment |
| 04/24/2013 | CN101611036B Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 04/24/2013 | CN101605793B Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 04/24/2013 | CN101555284B Truncated-type human ciliary nerve nutrition factor active segment and fusion protein thereof |
| 04/24/2013 | CN101553475B Hydroxamates as inhibitors of histone deacetylase |
| 04/24/2013 | CN101531703B Beta lamellar blocking peptide for preventing and/or curing Alzheimer's disease |
| 04/24/2013 | CN101528689B Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
| 04/24/2013 | CN101501049B Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 04/24/2013 | CN101472880B Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides |
| 04/24/2013 | CN101370494B Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| 04/23/2013 | US8426468 Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism |
| 04/23/2013 | US8426431 Substituted 2-aminoacetamides and the use thereof |
| 04/23/2013 | US8426427 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 04/23/2013 | US8426414 Modulators of G protein-coupled receptor 88 |
| 04/23/2013 | US8426403 Gamma secretase modulators |
| 04/23/2013 | US8426400 β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 04/23/2013 | US8426205 Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 04/23/2013 | US8426130 Methods of diagnosing alzheimer's disease and markers identified by set association |
| 04/23/2013 | US8425938 Pharmaceutical composition |
| 04/23/2013 | CA2623047C 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5 amine |
| 04/23/2013 | CA2595208C Therapeutic agents for sensory disorders |
| 04/23/2013 | CA2575663C Antibodies directed against amyloid-beta peptide and methods using same |
| 04/23/2013 | CA2549954C Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 04/23/2013 | CA2548276C Keto lactam compounds and use thereof |
| 04/23/2013 | CA2497255C Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 04/23/2013 | CA2475102C Stabilized synthetic immunogen delivery systems |
| 04/23/2013 | CA2400838C Novel method for down-regulation of amyloid |
| 04/18/2013 | WO2013056232A2 Rxr agonists compounds and methods |
| 04/18/2013 | WO2013056229A1 The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain |
| 04/18/2013 | WO2013056181A1 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| 04/18/2013 | WO2013056105A2 INHIBITION OF SPINAL MAMMALIAN TARGET OF RAPAMYCIN (mTOR) REDUCES CANCER PAIN, OPIOID TOLERANCE, AND HYPERALGESIA |
| 04/18/2013 | WO2013055922A1 Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability |
| 04/18/2013 | WO2013055865A1 Micrornas in neurodegenerative disorders |
| 04/18/2013 | WO2013055833A1 Dosage regimen for a sip receptor agonist |
| 04/18/2013 | WO2013055687A2 R(+)-n-formyl-propargyl-aminoindan |
| 04/18/2013 | WO2013055386A2 Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| 04/18/2013 | WO2013055385A2 Methods of treating age related disorders |
| 04/18/2013 | WO2013055127A2 Pharmaceutical composition for preventing and treating dementia, parkinson's disease or epilepsy, containing houttuynia cordata thunb. extract as active ingredient |
| 04/18/2013 | WO2013054940A1 Therapeutic agent and preventive agent for demyelinating disease |
| 04/18/2013 | WO2013054866A1 Agent for preventing or treating htlv-i associated myelopathy |
| 04/18/2013 | WO2013054822A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/18/2013 | WO2013054582A1 Orally dispersible tablet |
| 04/18/2013 | WO2013054534A1 DRUGS FOR DISEASES ASSOCIATED WITH AMYLOID β, AND SCREENING THEREFOR |
| 04/18/2013 | WO2013054291A1 Novel oxazine derivatives and their use in the treatment of disease |
| 04/18/2013 | WO2013054267A1 Synergistic composition for preventing and treating disorders connected with ageing |
| 04/18/2013 | WO2013054185A1 Pyrimidine and pyridine derivatives useful in therapy |
| 04/18/2013 | WO2013054108A1 Mono-fluoro beta-secretase inhibitors |
| 04/18/2013 | WO2013054001A1 Raising and diagnosing of serotonin level |
| 04/18/2013 | WO2013053954A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases |
| 04/18/2013 | WO2013053746A1 Composition for the prophylactic treatment of neuropathic pain |
| 04/18/2013 | WO2013053725A1 2-oxo-piperidinyl derivatives |
| 04/18/2013 | WO2013053690A1 Pde9i with imidazo pyrazinone backbone |
| 04/18/2013 | WO2013053485A1 Formulations containing quetiapine |
| 04/18/2013 | WO2013053287A1 Derivative of butylphthalide and preparation method and use thereof |
| 04/18/2013 | WO2013053050A1 Tubulin-interacting protein, caltubin, promotes axonal growth |
| 04/18/2013 | WO2012065102A8 S-t-butyl protected cysteine di-peptide analogs and related compounds |
| 04/18/2013 | US20130096170 Methods of treating pediatric patients using dexmedetomidine |
| 04/18/2013 | US20130096137 Treating Sexual Desire Disorders with Flibanserin |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096113 Heterocyclic compounds and methods of use thereof |
| 04/18/2013 | US20130096066 Pharmaceutical formulation for reducing pain |
| 04/18/2013 | US20130095194 Use of inhaled nitrous oxide or xenon for preventing neuropathic pain caused by cancer chemotherapy |
| 04/18/2013 | US20130095107 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 04/18/2013 | US20130095089 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| 04/18/2013 | US20130095087 Absorbable in situ gel-forming system, method of making and use thereof |
| 04/18/2013 | US20130095069 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 04/18/2013 | US20130095060 Pharmaceutical composition for promoting arteriogenesis, and preparation method and applications for the same |
| 04/18/2013 | DE112011102349T5 Pharmazeutische Zusammensetzung und Behandlungsverfahren The pharmaceutical composition and method of treatment |
| 04/18/2013 | CA2852057A1 3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| 04/18/2013 | CA2851805A1 Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability |
| 04/18/2013 | CA2851780A1 Methods of treating pediatric patients using dexmedetomidine |
| 04/18/2013 | CA2851761A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases |
| 04/18/2013 | CA2851741A1 Derivative of butylphthalide and preparation method and use thereof |
| 04/18/2013 | CA2851619A1 The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain |
| 04/18/2013 | CA2851525A1 Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
| 04/18/2013 | CA2851445A1 Novel oxazine derivatives and their use in the treatment of disease |
| 04/18/2013 | CA2851433A1 R(+)-n-methyl-propargyl-aminoindan |
| 04/18/2013 | CA2851280A1 Micrornas in neurodegenerative disorders |
| 04/18/2013 | CA2851276A1 R(+)-n-formyl-propargyl-aminoindan |
| 04/18/2013 | CA2851274A1 Rasagiline citramide |
| 04/18/2013 | CA2851087A1 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/18/2013 | CA2850707A1 Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| 04/18/2013 | CA2850514A1 Peptide inhibitors of bace1 |
| 04/18/2013 | CA2849385A1 2-oxo-piperidinyl derivatives |
| 04/17/2013 | EP2581451A1 Compounds for inhibiting mammalian s-nitrosoglutathione reductase |
| 04/17/2013 | EP2581373A1 Benzo- or pyrido-imidazole derivative |
| 04/17/2013 | EP2581088A1 New use of icariin and epimedium flavonoids containing icariin |
| 04/17/2013 | EP2581087A1 Composition containing iridoids and uses thereof |
| 04/17/2013 | EP2581084A1 Solid dispersion comprising triazole compound |
| 04/17/2013 | EP2580217A2 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580216A2 8-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |